Search Options Stock News and Analysis from Schaeffer's

SEARCH RESULTS FOR: "Tag: MDGL"

REFINE YOUR SEARCH

REFINE YOUR SEARCH:

ARTICLES/BLOGS

2024(1)

2022(1)

2018(3)

2017(2)

CATEGORIES

Analyst Update(2)

Buzz Stocks(3)

Intraday Option Activity(1)

Opening View(1)

Stocks On the Move(2)

Biotech Stock Soars on FDA Drug Approval

https://www.schaeffersresearch.com/content/news/2024/03/15/biotech-stock-soars-on-fda-drug-approval

3/15/2024 11:04 AM

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) stock is taking off today, after the U.S. Food & Drug Administration (FDA) approved the biotech company's drug for the treatment of non-alcoholic steatohepa...

Madrigal's Successful Late-Stage Trial Draws Options Bulls

https://www.schaeffersresearch.com/content/options/2022/12/19/madrigal%27s-successful-late-stage-trial-draws-options-bulls

12/19/2022 3:15 PM

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) is surging, last seen up 250.3% to trade at $223.50, after its experimental drug Resmetirom met the main goals of a late-stage study. Specifically, the dru...

Analysts Lower Expectations on Pharma Stocks IRWD and MDGL

https://www.schaeffersresearch.com/content/news/2018/11/19/analysts-lower-expectations-on-pharma-stocks-irwd-and-mdgl

11/19/2018 9:13 AM

Drug stocks Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) have both been struggling on the charts in recent months, and Wall Street is reacting. That is...

2 Stocks Swinging Higher on Trump Tariff News

https://www.schaeffersresearch.com/content/news/2018/09/18/2-stocks-swinging-higher-on-trump-tariff-news

9/18/2018 2:00 PM

Stocks are higher today as Wall Street brushes off the latest headlines in the U.S.-China trade spat. Drilling down on individual names making notable moves today, wearable tech firm Fitbit Inc (NYS...

2 Surging Drug Stocks

https://www.schaeffersresearch.com/content/news/2018/05/31/2-surging-drug-stocks

5/31/2018 10:07 AM

Canaccord Genuity upgraded Biogen Inc (NASDAQ:BIIB) to "buy" from "hold," saying it likes "the potential for the stock to benefit from a fear-of-missing-out rally as more data points crop up on BIIB'...

PEOPLE ALSO SEARCH FOR